- Home
- LQDA vs TRMD Comparison
LQDA vs TRMD Comparison
Compare LQDA & TRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LQDA | TRMD |
|---|---|---|
| Founded | 2004 | 1889 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Marine Transportation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.0B | 3.5B |
| IPO Year | 2020 | 2016 |
Fundamental Metrics
Financial Performance| Metric | LQDA | TRMD |
|---|---|---|
| Price | $47.98 | $34.67 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 2 |
| Target Price | ★ $54.38 | $44.50 |
| AVG Volume (30 Days) | ★ 3.9M | 1.5M |
| Earning Date | 11-10-2026 | 11-04-2026 |
| Dividend Yield | N/A | ★ 14.97% |
| EPS Growth | ★ 51.81 | N/A |
| EPS | ★ 1.26 | N/A |
| Revenue | ★ $158,320,000.00 | N/A |
| Revenue This Year | $357.27 | $21.41 |
| Revenue Next Year | $1.34 | N/A |
| P/E Ratio | $35.40 | ★ $9.61 |
| Revenue Growth | ★ 1031.18 | N/A |
| 52 Week Low | $22.31 | $19.30 |
| 52 Week High | $93.61 | $43.31 |
Technical Indicators
Market Signals| Indicator | LQDA | TRMD |
|---|---|---|
| Relative Strength Index (RSI) | 55.64 | 37.71 |
| Support Level | $35.00 | $31.76 |
| Resistance Level | $63.46 | $42.59 |
| Average True Range (ATR) | 3.10 | 1.59 |
| MACD | 1.61 | -0.91 |
| Stochastic Oscillator | 77.29 | 4.74 |
Price Performance
Historical ComparisonAbout LQDA Liquidia Corporation
Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also conducting studies on L606, an investigational, liposomal formulation of treprostinil.
About TRMD TORM plc
TORM PLC operates as a shipping company mainly owning and operating a fleet of product tankers. It is engaged in the transportation of refined oil products and clean petroleum products, including gasoline, jet fuel, naphtha, and diesel oil. The Company operates through two segments: the Tanker segment and the Marine Engineering segment, deriving the majority of its revenue from the Tanker segment.